This is not the most recent version of the article. View current version (30 AUG 2013)

Intervention Protocol

You have free access to this content

Topiramate for neuropathic pain and fibromyalgia in adults

  1. Philip J Wiffen1,
  2. Sheena Derry1,*,
  3. Michael PT Lunn2,
  4. R Andrew Moore1

Editorial Group: Cochrane Neuromuscular Group

Published Online: 31 MAY 2013

DOI: 10.1002/14651858.CD008314.pub2


How to Cite

Wiffen PJ, Derry S, Lunn MPT, Moore RA. Topiramate for neuropathic pain and fibromyalgia in adults (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD008314. DOI: 10.1002/14651858.CD008314.pub2.

Author Information

  1. 1

    University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK

  2. 2

    National Hospital for Neurology and Neurosurgery, Department of Neurology and MRC Centre for Neuromuscular Diseases, London, UK

*Sheena Derry, Pain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Pain Research Unit, Churchill Hospital, Oxford, Oxfordshire, OX3 7LE, UK. sheena.derry@ndcn.ox.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 31 MAY 2013

SEARCH

This is not the most recent version of the article. View current version (30 AUG 2013)

References

Additional references

Antel 2012
Apkarian 2011
AUREF 2012
  • PaPaS author and referee guidance. http://papas.cochrane.org/papas-documents (accessed 22 January 2013).
Birse 2012
Bouhassira 2008
Chong 2003
Chronicle 2004
Corrigan 2012
Derry 2012
Derry 2013
Dworkin 2008
Gill 2011
Green 2012
Gustorff 2008
Hall 2008
Higgins 2011
  • Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011. Available from www.cochrane-handbook.org.
Jadad 1996
Jensen 2011
  • Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, et al. A new definition of neuropathic pain. Pain 2011; Vol. 152, issue 10:2204-5. [DOI: 10.1016/j.pain.2011.06.017]
Jette 2002
Kanda 1996
Katusic 1991
  • Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984. Neuroepidemiology 1991;10(5-6):276-81.
Khaliq 2007
Koopman 2009
Koroschetz 2011
L'Abbé 1987
Lunn 2009
McNally 2006
  • McNally JD, Matheson DA, Bakowsky VS. The epidemiology of self-reported fibromyalgia in Canada. Chronic Diseases in Canada 2006;27(1):9-16.
McQuay 1998
  • McQuay H, Moore R. An Evidence-Based Resource for Pain Relief. Oxford: Oxford University Press, 1998. [ISBN: 0-19-263048-2]
McQuay 2007
  • McQuay HJ, Smith LA, Moore RA. Chronic Pain. In: Stevens A, Raftery J, Mant J, Simpson S editor(s). Health Care Needs Assessment: The Epidemiologically Based Needs Assessment Reviews: Third Series. Oxford: Radcliffe Publishing, 2007. [ISBN: 978-1-84619-063-6]
Moisset 2007
Moore 1998
Moore 2008
  • Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978–0–931092–69–5]
Moore 2009
Moore 2010a
Moore 2010b
Moore 2010c
Moore 2010d
  • Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374-9. [DOI: doi:10.1136/ard.2009.107805]
Moore 2011
  • Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2]
Moore 2011a
  • Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2]
Moore 2011b
  • Moore RA, Straube S, Paine J, Derry S, McQuay HJ. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011;152(5):982-9. [DOI: doi:10.1016/j.pain.2010.11.030]
Moore 2011c
Moore 2012a
Moore 2012b
Moore 2013a
  • Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice 2013;March 6:Epub ahead of print. [DOI: 10.1111/papr.12050]
Moore 2013b
O'Brien 2010
O'Connor 2009
Rappaport 1994
RevMan 2012 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Soni 2013
  • Soni A, Batra R, Gwilym S, Spector T, Hart D, Arden N, et al. Neuropathic features of joint pain: A community-based study. Arthritis & Rheumatism 2013;April 1:Epub ahead of print. [DOI: 10.1002/art.37962]
Straube 2008
Straube 2010
  • Straube S, Derry S, Moore RA, Paine J, McQuay HJ. Pregabalin in fibromyalgia--responder analysis from individual patient data. BMC Musculoskeletal Disorders 2010;11:150. [doi: 10.1186/1471-2474-11-150]
Sultan 2008
Sun 2006
Torrance 2006
Tracey 2011
Treede 2008
Vos 2012
Walia 2004
Wiffen 2010
Wiffen 2011a
Wiffen 2011b
Wolfe 1990
Wolfe 2010